ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

GDR Genedrive Plc

1.625
-0.125 (-7.14%)
27 Jun 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Genedrive Plc LSE:GDR London Ordinary Share GB00B1VKB244 ORD 1.5P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -0.125 -7.14% 1.625 1.60 1.65 1.75 1.525 1.75 63,456,389 16:19:22
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Coml Physical, Biologcl Resh 55k -5.15M -0.0095 -1.71 8.8M
Genedrive Plc is listed in the Coml Physical, Biologcl Resh sector of the London Stock Exchange with ticker GDR. The last closing price for Genedrive was 1.75p. Over the last year, Genedrive shares have traded in a share price range of 1.425p to 17.50p.

Genedrive currently has 543,141,481 shares in issue. The market capitalisation of Genedrive is £8.80 million. Genedrive has a price to earnings ratio (PE ratio) of -1.71.

Genedrive Share Discussion Threads

Showing 6451 to 6473 of 27050 messages
Chat Pages: Latest  266  265  264  263  262  261  260  259  258  257  256  255  Older
DateSubjectAuthorDiscuss
10/2/2021
09:29
buyers pushing this up more






Distribution agreement with Beckman Coulter Life Sciences for COVID-19 PCR testing



genedrive plc (AIM: GDR), the near patient molecular diagnostics company, announces that it has entered into a distribution agreement with Beckman Coulter Life Sciences ("Beckman Coulter") for its Genedrive® 96 SARS-CoV-2 Kit. The agreement enables Beckman Coulter to sell and distribute genedrive's high-throughput COVID-19 PCR Kit in the United States and Europe for use on upper respiratory viral samples. The agreement is the result of the collaboration agreement announced in August 2020, under which the companies worked to develop and validate a fully automated PCR process for Beckman Coulter's Biomek automated workstation in conjunction with its RNAdvance Viral XP extraction kit.



The Genedrive® 96 SARS-CoV-2 test is ideally suited for use on the high throughput robotic Biomek i7 instrument. The ready-to-go nature of the test removes many of the fluid dispensing steps required in competitor assays, increasing the overall throughput of the Biomek compared to using a liquid reagent based test formulation. Full automation of the overall PCR workflow can allow laboratories to run large numbers of tests over extended working hours or workstation platforms. Beckman Coulter estimates that this new turnkey solution could process circa 1,000 PCR samples per Biomek workstation installed during a standard 8-hour working day, using just a 0.5 full-time-equivalent in technician time for processing.

bunz3
10/2/2021
09:28
moving up again


as more buyers pick up more shares

bunz3
10/2/2021
09:28
so strong of buying


so nice to watch as more buy here as Mid February moves closer

bunz3
10/2/2021
09:27
like how sells being bought up


£2 might be seen before Friday with this buying

bunz3
10/2/2021
09:25
MreMutations Cummings
andymunchkin
10/2/2021
09:20
with this number of buyers who wanting shares Today

£2 might be reached before Friday

bunz3
10/2/2021
09:19
150 hit.. I have taken profits. Left a small amount in case it decides to do a 300
losses
10/2/2021
09:19
Are people still waiting for the handle ? :)

June - Sept 2020 could be that ... by the way ;)

This is STILL far too cheap

hooded claw
10/2/2021
09:19
strength of buying ,as they pick up sells
bunz3
10/2/2021
09:17
they buying up the sells is this an Institution buyer loading up on sells
bunz3
10/2/2021
09:13
NT to sell again
oilisgold
10/2/2021
09:10
Institution trying to build!
swerves1
10/2/2021
09:07
Added again
actybod
10/2/2021
08:54
OILISGOLD needs to exit his short position before he gets burned, hence the volume of negative deramping posts. He can't understand that a company with no debt and > a year of cash left doesn't need a placing when it's also on the cusp of product commercialisation, with orders for Genedrive 96 SARS-Cov-2 in the tens of millions imminent, and a huge distribution network already in place via Beckman salesforce and their installed base of Biomek i7
craffert
10/2/2021
08:54
shows the demand for shares , how soon sells being bought up this morning as share has moved up
bunz3
10/2/2021
08:50
so strong how soon they buying up any sells


so many loading up as getting closer to mid February

bunz3
10/2/2021
08:49
olls - got ur computer upside down???
mrshaungcm
10/2/2021
08:49
so much strength of buying

how soon any sells being bought up

bunz3
10/2/2021
08:48
Pathetic rampers
oilisgold
10/2/2021
08:48
RAMPERS RAMPING TO SRLL
oilisgold
10/2/2021
08:48
Nt to sell
oilisgold
10/2/2021
08:46
strength of buying ,how soon any sells being bought
bunz3
10/2/2021
08:40
they moving share price up faster ,looks like share supply running lower
bunz3
Chat Pages: Latest  266  265  264  263  262  261  260  259  258  257  256  255  Older